The following is the response I received to my inquiry back in November relative to the Company's capacity to manufacture the DurAVR valves -"Thanks for your email. Our team is heavily involved in manufacturingTAVR Heart valves for clinical trials, testing, new product development andclinical evaluation. We have tapped into a small proportion of our availablecapacity across our sites as we build up an inventory of valves for ourupcoming EFS and IDE trials. The Clinical roadmap ahead is both exciting andsignificant, meaning a considerable expansion and scale-up of current capacityis likely, as opposed to a contraction.
Please don’t hesitate to reach out if you have any other questions."
My assumption from that reply is that Anteris are doing it themselves.
The following is the response I received to my inquiry back in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.15 |
Change
0.150(2.50%) |
Mkt cap ! $95.31M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.15 | $6.00 | $41.13K | 6.816K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 165 | $6.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.20 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |